Navigation Links
Nobel Laureate Finds an Alternate Way to Manufacture Anti-Flu Drug

US researcher and a Nobel laureate hopes to manufacture plentiful anti-flu drugs at a cheaper cost. Tamiflu is the anti-flu drug and Elias Corey has work out the method while relaxing at home on a weekend. // The Swiss manufacturer Roche has manufactured the drug and given it to World Health Organization to prevent any outbreak of the disease. But the starting material (shikimic acid) for the production cycle is a compound extracted from the plant star anise. This is grown in mountain provinces in southwest China.

The compound at its heart has a ring of carbon molecules that makes a very particular template on which the rest of the drug can be built. The plant has to be harvested once a year, and Tamiflu production is now taking up most of the crop. Professor Corey won the Nobel Prize for Chemistry in 1990 for his successes in devising lab-bench approaches to synthesizing natural compounds. He used an old approach were mixtures of the useful and useless forms of complex molecules are formed, and then separated later. But it is a wasteful and time-consuming process. Hence he came to the rescue of the Roche's problem. In just about eight weeks time the whole process had been worked through and refined, and the product compared with genuine Tamiflu. The entire process elaborated in the online edition of the Journal of the American Chemical Society.


'"/>




Page: 1

Related medicine news :

1. Nobel Prize for Medicine shared by Three scientists
2. Stem cell research- now Nobel Laureates join the debate
3. Nobel laureates in chemistry
4. Nobel Prize for Medicine
5. Cholesterol Mystery Solved By Nobel Laureates
6. Nobel For Ulcer-Defying Aussie Scientists
7. Aussie Nobel Prize Winners Receive Their Awards
8. Dutch chemical group Akzo Nobel Develops A New Bird Flu Vaccine
9. Two Americans Share 2006 Nobel Medicine Prize
10. Nobel Prize – a ‘near miss’ for Indian Scientist coule
11. Nobel Prize for Gene ‘Silencing
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Nobel Laureate Finds Alternate Way Manufacture Anti Flu Drug

(Date:7/29/2015)... , ... July 29, 2015 , ... It is unique ... “This is a tremendous model of care. One that is very hands on and ... executive director of Monarch Landing. “She’s bringing great passion and energy, as well as ...
(Date:7/29/2015)... ... July 29, 2015 , ... Stealth ... a Clinical Performance Study for the Invisiport at Wheaton Franciscan Healthcare in Milwaukee, ... options, offers a less invasive, patient-friendly alternative to traditional chest ports and peripherally ...
(Date:7/29/2015)... ... ... TransFlip is an all new dynamic transition pack for FCPX, containing flipping ... are easy to apply and modify for any skill-level user. TransFlip includes custom bounce ... kinetic flipping panel animations are just a few clicks away. , TransFlip contains over ...
(Date:7/29/2015)... ... July 29, 2015 , ... Zofran lawsuits around the ... Multidistrict Litigation (JPML), according to court documents.* Attorneys handling Zofran lawsuits ... Birth Defects Lawsuit Center. , GlaxoSmithKline, the global pharmaceutical conglomerate and defendant in ...
(Date:7/29/2015)... , ... July 29, 2015 , ... The New ... project, which will by the end will cost the 501(c) organization nearly $1 million, ... recent anti-ligature requirements. , “We took it down to the studs,” said Geraldine ...
Breaking Medicine News(10 mins):Health News:New Medical Director Readies To Take Reins at Monarch Landing 2Health News:New Medical Director Readies To Take Reins at Monarch Landing 3Health News:Stealth Therapeutics Inc. Enrolls First Patients in a Clinical Performance Study for the Invisiport Product Line 2Health News:Stealth Therapeutics Inc. Enrolls First Patients in a Clinical Performance Study for the Invisiport Product Line 3Health News:Pixel Film Studios Releases FCPX Transition TransFlip for FCPX 2Health News:Zofran Lawsuit News: Zofran Lawsuits Stayed, Awaiting MDL Decision 2Health News:Zofran Lawsuit News: Zofran Lawsuits Stayed, Awaiting MDL Decision 3Health News:Zofran Lawsuit News: Zofran Lawsuits Stayed, Awaiting MDL Decision 4Health News:The New Foundation AZ Renovates Residential Dorms for Youth in Crisis 2Health News:The New Foundation AZ Renovates Residential Dorms for Youth in Crisis 3
... takes a complete snapshot of adolescent cardiovascular health in the ... likely to die of heart disease at a younger age ... "We are all born with ideal cardiovascular health, but ... health in youth," said Donald Lloyd-Jones, M.D., chair and associate ...
... is the recipient of one of Canada,s top awards ... the mammalian immune system, Kubes will accept the 2011 ... Canadian Institutes of Health Research (CIHR) at a ceremony ... Kubes for winning this prestigious award," said the Honourable ...
... Like a gardener who stakes some plants and weeds ... synapses, while pruning out redundant or unneeded synapses. Researchers ... Zhang, Ph.D., have discovered a factor in synapse-building, also ... of each other. Mammals are born with functioning ...
... The American Academy of Orthopaedic Surgeons (AAOS) Board of ... practice guideline (CPG) on "The Treatment of Supracondylar Humerus ... surgeon, medical director of the Trauma Program at the ... chair of the AAOS Work Group responsible for this ...
... Aging Society and Services and Advocacy for GLBT ... acclaimed Public Policy & Aging Report (PPAR) on ... policy and research on LGBT older adults, and current and ... "Given the voluminous gerontological literature that has built up over ...
... less produce the finest foie gras that rich, buttery ... eaten as slices atop lightly toasted bread scientists are ... and Food Chemistry. Caroline Molette and colleagues explain ... gras, a traditional French dish, comes from its high fat ...
Cached Medicine News:Health News:Today's teens will die younger of heart disease 2Health News:Today's teens will die younger of heart disease 3Health News:University of Calgary researcher named Canada's Health Researcher of the Year 2Health News:University of Calgary researcher named Canada's Health Researcher of the Year 3Health News:Jackson Laboratory researchers uncover steps in synapse building, pruning 2Health News:AAOS issues new clinical practice guideline for treating common elbow fractures in children 2Health News:New report highlights LGBT older adults' needs, identifies policy opportunities 2
(Date:7/29/2015)... YORK , July 29, 2015 /PRNewswire/ ... a new research report "Global Industry Insight: ... to 2020" with market overview, trends, DRO analysis, ... analysis, recent developments, competitive scenario and top ... http://photos.prnewswire.com/prnh/20150727/756778 ) Microfluidic devices  ...
(Date:7/29/2015)... LONDON , July 29, 2015 ... the Novartis transaction closed, CFO Simon Dingemans ... acquired businesses are performing in line with expectations. Ahead ... company,s commitment to sustainable innovation. The interview ... MerchantCantos produces in-depth interviews, documentaries and webcasts ...
(Date:7/29/2015)... , July 29, 2015  Cepheid (Nasdaq: ... an update to Xpert® Carba-R, with the addition ... OXA-232.  The on-demand, molecular test also detects and ... carbapenem resistance, namely KPC, NDM, VIM, IMP-1 and ... as CROs or Superbugs, are a growing and ...
Breaking Medicine Technology:Global Microfluidic Devices Market (Size of $1,886 Million in 2014) to Witness a CAGR of 23% During 2015 - 2020 2Global Microfluidic Devices Market (Size of $1,886 Million in 2014) to Witness a CAGR of 23% During 2015 - 2020 3Global Microfluidic Devices Market (Size of $1,886 Million in 2014) to Witness a CAGR of 23% During 2015 - 2020 4Global Microfluidic Devices Market (Size of $1,886 Million in 2014) to Witness a CAGR of 23% During 2015 - 2020 5'Superbug' Test Updated to Identify Newest Carbapenem-Resistant Organisms 2'Superbug' Test Updated to Identify Newest Carbapenem-Resistant Organisms 3'Superbug' Test Updated to Identify Newest Carbapenem-Resistant Organisms 4
...   Heska Corporation (NASDAQ: HSKA - ... veterinary products, today announced it is to present at the ... May 23, 2012 at the Loews Santa Monica Beach Hotel, ... The presentation is scheduled to begin at 1 p.m. Pacific ...
... (OTC Bulletin Board: NEPH ), a global ... therapeutic applications, infection control, and water purification, announced today ... 2012. Recent Highlights , ... U.S. , Executed strategic license and supply agreement ...
Cached Medicine Technology:Nephros Reports First Quarter 2012 Financial Results 2Nephros Reports First Quarter 2012 Financial Results 3Nephros Reports First Quarter 2012 Financial Results 4Nephros Reports First Quarter 2012 Financial Results 5Nephros Reports First Quarter 2012 Financial Results 6Nephros Reports First Quarter 2012 Financial Results 7Nephros Reports First Quarter 2012 Financial Results 8
For the quantitative in vitro determination of Uric Acid in serum, plasma and urine...
For the quantitative in vitro determination of apolipoprotein A-1 (apo A-1) in serum and plasma. For use as an aid if assessing the risk of coronary artery disease....
For the quantitative in vitro determination of Urea in serum, plasma and urine....
The XTRI method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of triglycerides in serum and plasma....
Medicine Products: